Pharmacyclics

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Celgene
Gilead Sciences
Express Scripts
Biogen Idec
Amicus Therapeutics
NPS Pharmaceuticals
Sanofi
Acadia
Orexigen
Pharmacyclics
Vertex Pharmaceuticals
At Pharmacyclics, Employees Train To Become Geniuses Thanks To CEO
Investors.com
Wed, 01/7/15 - 11:43 am
Pharmacyclics
Imbruvica performs well in high-risk leukemia patients
Seeking Alpha
Mon, 01/5/15 - 04:10 pm
Imbruvica
CLL
chronic lymphocytic leukemia
Pharmacyclics
At Pharmacyclics, Employees Train To Become Geniuses
Investor's.com
Sat, 01/3/15 - 10:44 am
Pharmacyclics
IMBRUVICA® (ibrutinib) Data Suggests Promise in Multiple Myeloma
Yahoo/PR Newswire
Sun, 12/7/14 - 09:57 am
Imbruvica
Multiple Myeloma
Janssen
Pharmacyclics
Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
RTT News
Mon, 10/13/14 - 10:14 am
Bristol-Myers Squibb
Pharmacyclics
Janssen
Opdivo
Imbruvica
Pharmacyclics, Servier call it quits on a cancer drug
Fierce Biotech
Fri, 09/26/14 - 09:05 am
Pharmacyclics
Servier
Abexinostat
Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Mon, 09/22/14 - 08:37 am
Gilead Sciences
JNJ
Pharmacyclics
Imbruvica
Zydelig
Most popular news headlines for Friday, August 1 2014
CP Wire
Sat, 08/2/14 - 09:35 am
Sanofi
Pharmacyclics
layoffs
Jardiance
Imbruvica
Eli Lilly
diabetes
Boehringer Ingelheim
Amgen
Most popular news headlines for Friday, August 1 2014
Sat, 08/2/14 - 09:32 am
Sanofi
Pharmacyclics
layoffs
Jardiance
Imbruvica
Eli Lilly
diabetes
Boehringer Ingelheim
Amgen
The Best Blood Cancer Drug Launch Ever?
Forbes
Fri, 08/1/14 - 10:27 am
Pharmacyclics
Imbruvica
leukemia
4 Top Biotechs Expected to Beat Earnings Expectations
24/7 Wall St
Wed, 07/16/14 - 10:36 am
earnings
Amgen
Gilead Sciences
Pharmacyclics
Seattle Genetics
Pharmacyclics reports sNDA for Imbruvica accepted, priority review granted
The Fly on the Wall
Mon, 06/9/14 - 09:45 am
Pharmacyclics
Imbruvica
Pharmacyclics' Imbruvica Extends Survival in Elderly Leukemia Patients
The Street
Sat, 05/31/14 - 10:32 am
Pharmacyclics
Imbruvica
leukemia
1 Biotech Refusing to Stick Its Neck Out
Motley Fool
Mon, 05/19/14 - 09:34 am
Pharmacyclics
Imbruvica
Biotech Bad News Buys
Motley Fool
Fri, 05/16/14 - 11:32 am
Seattle Genetics
Endocyte
Pharmacyclics
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
1 Company Johnson & Johnson Should Buy
Motley Fool
Wed, 05/7/14 - 03:33 pm
JNJ
Pharmacyclics
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock
Yahoo/Zacks.com
Mon, 05/5/14 - 11:32 am
earnings
Pharmacyclics
Say Hello to 3 Existing and Upcoming Next-Generation Blockbuster Drugs
Motley Fool
Sun, 04/27/14 - 09:51 am
Sovaldi
Gilead Sciences
Imbruvica
Pharmacyclics
JNJ
Eliquis
Bristol-Myers Squibb
Pfizer

Pages